Myogrel in the management of ACS

Now you can view the excellent lecture of:

Dr Mohammad Gamal Abd AlAziz, Consultant of Cardiology, Assiut,

on the ESC guidelines for the management of non-ST elevation acute coronary syndromes.

This was presented during Adwia's meeting, TUT hotel, Assiut, July 2012.

Just follow this link:

Special tastes for Randil & Myogrel, Dubai 2012

Know the special tastes for Myogrel & Randil, by the Egyptian clinical researches on them, through Adwia's meeting, Dubai 2012;

"The Egyptian CV Experiences"

Chairpersons:

Dr Mahmoud Hasaneen, Professor of Cardiology Alexandria University.

Dr Abd AlFattah Ferer, Professor of Cardiology Zagazig University.

Dr Mohammad Gamal, Professor of Cardiology, Assiut.

Speakers:

Dr Tarek AlZawawy, Professor of Cardiology Alexandria University.

“Modern managements of stable angina”

Dr Waled Ammar, Ass. Professor of Cardiology, Cairo University.

“The Egyptian Experience in Clopidogrel”

You can get PDF formats of the presentations here:

         

Here are sample photos for the meeting:

TRUST study on Myogrel, BMJ, June 2012.

Now you can review the full details of TRUST study, evaluating the use of Myogrel (Clopidogrel 75mg) in 369 patients undergoing elective PCI with bare metal stent insertion, with a 3 months follow up period.
Published in BMJ, middle east, June 2012.

Just follow the link below..

Introduction

• Myogrel (Clopidogrel 75mg), is an Egyptian antiplatelet brand, indicated to reduce the risk of thrombotic events, in patients with acute coronary syndromes, recent stroke, transient ischemic attacks or established peripheral arterial disease.

• Myogrel has been launched in the Egyptian market, by Adwia pharmaceutical company, since November 2005.

• Myogrel is manufactured in Adwia company under the supervision of two ISO certificates (ISO 9001 & ISO 14001). To visit the full website of Adwia, click here.

• Myogrel reaches your patient in a high quality pack; double Aluminum strip, to protect the drug from light & moisture throughout shelf life.

• Myogrel had been recommended in 10 University hospitals, and has been prescribed in over 150,000 Rx by physicians all over Egypt.

• Myogrel was proved to be bioequivalent with the reference brand (bioequivalnce study, center of applied research & advanced studies, Cairo University, 2006).

• Myogrel is offered with an optimum price; 120 LE / 30 tablets, saving 45% from the monthly cost of the reference Clopidogrel.

    Myogrel, A Brand You Can Trust.